IMUX
Immunic Inc

12,465
Mkt Cap
$78.87M
Volume
830,351.00
52W High
$1.39
52W Low
$0.5062
PE Ratio
-0.72
IMUX Fundamentals
Price
$0.6201
Prev Close
$0.6557
Open
$0.6607
50D MA
$0.6365
Beta
1.56
Avg. Volume
1.59M
EPS (Annual)
-$1.00
P/B
5.83
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Immunic (NASDAQ:IMUX) Trading Down 2.1% - Here's Why
Immunic (NASDAQ:IMUX) Shares Down 2.1% - Time to Sell...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Immunic (NASDAQ:IMUX) Shares Up 9.3% - Should You Buy?
Immunic (NASDAQ:IMUX) Shares Up 9.3% - Here's What Happened...
MarketBeat·30d ago
News Placeholder
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Analysts
Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been assigned a consensus recommendation of "Buy" from the eight research firms that are presently covering the company, MarketBeat reports. One...
MarketBeat·2mo ago
News Placeholder
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December PR Newswire NEW YORK...
PR Newswire·2mo ago
News Placeholder
Analysts Offer Predictions for Immunic FY2025 Earnings
Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Chardan Capital issued their FY2025 earnings per share estimates for Immunic in a research note issued to investors on Wednesday...
MarketBeat·2mo ago
News Placeholder
Equities Analysts Issue Forecasts for Immunic Q1 Earnings
Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Brookline Capital Management issued their Q1 2026 earnings estimates for shares of Immunic in a research report issued to clients...
MarketBeat·3mo ago
News Placeholder
HC Wainwright Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00
HC Wainwright lowered their target price on shares of Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a research note on Friday...
MarketBeat·3mo ago
News Placeholder
Immunic (NASDAQ:IMUX) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Immunic (NASDAQ:IMUX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.05...
MarketBeat·3mo ago
News Placeholder
D. Boral Capital Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00
D. Boral Capital reduced their target price on Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a report on Thursday...
MarketBeat·3mo ago
News Placeholder
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire NEW YORK...
PR Newswire·3mo ago
<
1
2
...
>

Latest IMUX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.